GlassScriptPhysician profile
Holly Wuest
NPI 1588932172
$6,986.15
in general payments reported to CMS, 2019-2025
30 companies · $1,879 in 2025
The $1,879 reported for 2025 was more than what 94% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,413 · 2022: $1,096 · 2023: $1,004 · 2024: $1,594 · 2025: $1,879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,477.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,955.05 | 2021-2025 | Tezspire, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $1,141.25 | 2021-2025 | Arexvy, Trelegy Ellipta, Nucala |
| Regeneron Healthcare Solutions, INC. | $443.76 | 2021-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $422.33 | 2021-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Avadel Cns Pharmaceuticals, LLC | $374.12 | 2024-2025 | Lumryz |
| Philips North America LLC | $345.96 | 2022-2025 | (Ak6) Vest Therapy, (8874) Incourage, Vest Therapy Und |
| Grifols USA, LLC | $293.04 | 2021-2025 | Prolastin-C Liquid |
| Baxter Healthcare | $273.64 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Genzyme Corporation | $254.78 | 2021-2025 | |
| United Therapeutics Corporation | $205.03 | 2021-2023 | |
| Amgen INC. | $196.83 | 2021-2025 | Tezspire |
| Harmony Biosciences LLC | $164.73 | 2022-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $155.19 | 2021-2025 | |
| Insmed, INC. | $107.45 | 2022 | |
| Axsome Therapeutics, INC. | $105.43 | 2024-2025 | Sunosi |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $97.47 | 2024 | Inspire |
| Verona Pharma, INC. | $66.95 | 2025 | Ohtuvayre |
| Janssen Pharmaceuticals, INC | $58.95 | 2021-2023 | Xarelto |
| Eisai INC. | $56.53 | 2021-2022 | |
| Electromed, INC. | $53.17 | 2023-2024 | Smartvest |
| Pfizer INC. | $37.35 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $33.32 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.12 | 2024 | Glassia |
| Pulmonx Corporation | $19.00 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Mylan Specialty L.P. | $18.87 | 2022 | |
| Phadia US INC. | $17.82 | 2023 | Immunocap |
| Viatris Specialty LLC | $16.38 | 2025 | Yupelri |
| Merck Sharp & Dohme LLC | $14.96 | 2022 | |
| Lilly USA, LLC | $14.83 | 2025 | Zepbound |
| Breas Medical, INC. | $13.84 | 2024 | Vivo 45 Ls |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Wuest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.